Evidence map›Paper›PMID 35953676›Full record

ArticleIntensive care medicine2022

Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years.

Boacheng Wang, Josef Briegel, Wolfgang A Krueger, Rika Draenert, Jette Jung, Alexandra Weber, Johannes Bogner, Sören Schubert, Uwe Liebchen, Sandra Frank and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Update on infection prevention in the ICU.Current opinion in critical care · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  9. Review
  10. Gut Microbiome in Sepsis.Surgical infections · 2023
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Boacheng WangDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Josef BriegelDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. josef.briegel@med.lmu.de.ORCID http://orcid.org/0000-0003-2837-8008
Wolfgang A KruegerDepartment of Anesthesiology, Klinikum Konstanz, Constance, Germany.
Rika DraenertInterdisciplinary Antibiotic Stewardship Team, University Hospital, LMU Munich, Munich, Germany.
Jette JungInterdisciplinary Antibiotic Stewardship Team, University Hospital, LMU Munich, Munich, Germany.
Alexandra WeberInterdisciplinary Antibiotic Stewardship Team, University Hospital, LMU Munich, Munich, Germany.
Johannes BognerDepartment of Medicine IV, Infectious Diseases, University Hospital, LMU Munich, Munich, Germany.
Sören SchubertDepartment of Medical Microbiology and Hospital Hygiene, Max-Von-Pettenkofer Institute, LMU Munich, Munich, Germany.
Uwe LiebchenDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Sandra FrankDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Michael ZollerDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Michael IrlbeckDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Ludwig NeyDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Thomas WeigDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Ludiwg HinskeDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Sebastian NiedermayerDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Erich KilgerDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Patrick MöhnleDepartment of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Beatrice GrabeinClinical Microbiology and Hospital Hygiene, University Hospital, LMU Munich, Munich, Germany.
LMU Klinikum · DEInstitute of Medical Microbiology and Hygiene · DEKlinikum Konstanz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis case-control study investigated the long-term evolution of multidrug-resistant bacteria (MDRB) over a 5-year period associated with the use of selective oropharyngeal decontamination (SOD) in the intensive care unit (ICU). In addition, effects on health care-associated infections and ICU mortality were analysed.

methodsWe investigated patients undergoing mechanical ventilation > 48 h in 11 adult ICUs located at 3 campuses of a university hospital. Administrative, clinical, and microbiological data which were routinely recorded electronically served as the basis. We analysed differences in the rates and incidence densities (ID, cases per 1000 patient-days) of MDRB associated with SOD use in all patients and stratified by patient origin (outpatient or inpatient). After propensity score matching, health-care infections and ICU mortality were compared.

results5034 patients were eligible for the study. 1694 patients were not given SOD. There were no differences in the incidence density of MDRB when SOD was used, except for more vancomycin-resistant Enterococcus faecium (0.72/1000 days vs. 0.31/1000 days, p < 0.01), and fewer ESBL-producing Klebsiella pneumoniae (0.22/1000 days vs. 0.56/1000 days, p < 0.01). After propensity score matching, SOD was associated with lower incidence rates of ventilator-associated pneumonia and death in the ICU but not with ICU-acquired bacteremia or urinary tract infection.

conclusionsComparisons of the ICU-acquired MDRB over a 5-year period revealed no differences in incidence density, except for lower rate of ESBL-producing Klebsiella pneumoniae and higher rate of vancomycin-resistant Enterococcus faecium with SOD. Incidence rates of ventilator-associated pneumonia and death in the ICU were lower in patients receiving SOD.

Indexed as

Cross InfectionPneumonia, Ventilator-AssociatedAdultAnti-Bacterial AgentsBacteriaCase-Control StudiesDecontaminationHumansIntensive Care UnitsVancomycinAnti-Bacterial AgentsVancomycinKlebsiella pneumoniae/drug effectsMethicillin-resistant Staphylococcus aureus/drug effectsPolymyxins/drug effectsPseudomonas aeruginosa/drug effectsSelective oral decontamination, selective digestive decontamination, antimicrobial resistance, intensive care units/statistics and numerical dataVancomycin/drug effects

Identifiers

PMID35953676
PMCPMC9463265
OpenAlexW4293298483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.